Joseph Douglas Lyon - Net Worth and Insider Trading
Joseph Douglas Lyon Net Worth
The estimated net worth of Joseph Douglas Lyon is at least $497,748 dollars as of 2024-11-29. Joseph Douglas Lyon is the See Remarks of Corcept Therapeutics Inc and owns about 8,494 shares of Corcept Therapeutics Inc (CORT) stock worth over $497,748. Details can be seen in Joseph Douglas Lyon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Douglas Lyon has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Douglas Lyon
Joseph Douglas Lyon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Douglas Lyon owns 1 companies in total, including Corcept Therapeutics Inc (CORT) .
Click here to see the complete history of Joseph Douglas Lyon’s form 4 insider trades.
Insider Ownership Summary of Joseph Douglas Lyon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2024-07-01 | Chief Accounting Officer |
Joseph Douglas Lyon Latest Holdings Summary
Joseph Douglas Lyon currently owns a total of 1 stock. Joseph Douglas Lyon owns 8,494 shares of Corcept Therapeutics Inc (CORT) as of November 22, 2024, with a value of $497,748.
Latest Holdings of Joseph Douglas Lyon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2024-11-22 | 8,494 | 58.60 | 497,748 |
Holding Weightings of Joseph Douglas Lyon
Joseph Douglas Lyon Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Douglas Lyon has made a total of 19 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 1,411 shares on November 22, 2024, which brought Joseph Douglas Lyon around $80,032.
Insider Trading History of Joseph Douglas Lyon
- 1
Joseph Douglas Lyon Trading Performance
Joseph Douglas Lyon Ownership Network
Joseph Douglas Lyon Owned Company Details
What does Corcept Therapeutics Inc do?
Who are the key executives at Corcept Therapeutics Inc?
Joseph Douglas Lyon is the Chief Accounting Officer of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include CHIEF FINANCIAL OFFICER Gary Charles Robb , Chief Development Officer William Guyer , and See Remarks Sean Maduck .
Corcept Therapeutics Inc (CORT) Insider Trades Summary
Over the past 18 months, Joseph Douglas Lyon made 16 insider transaction in Corcept Therapeutics Inc (CORT) with a net sale of 71,411. Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 30,950 shares made by Swisher Daniel N Jr , a net sale of 225,000 shares made by Sean Maduck , and a net sale of 100,000 shares made by William Guyer .
In summary, during the past 3 months, insiders sold 47,220 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 47,220 shares. During the past 18 months, 524,119 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 524,119 shares.
Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corcept Therapeutics Inc Insider Transactions
Joseph Douglas Lyon Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Douglas Lyon. You might contact Joseph Douglas Lyon via mailing address: C/o Corcept Therapeutics Incorporated, 149 Commonwealth Drive, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
